[go: up one dir, main page]

PE20121472A1 - COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY - Google Patents

COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY

Info

Publication number
PE20121472A1
PE20121472A1 PE2012000650A PE2012000650A PE20121472A1 PE 20121472 A1 PE20121472 A1 PE 20121472A1 PE 2012000650 A PE2012000650 A PE 2012000650A PE 2012000650 A PE2012000650 A PE 2012000650A PE 20121472 A1 PE20121472 A1 PE 20121472A1
Authority
PE
Peru
Prior art keywords
combination
theobromine
drugs
therapy
propoxycphene
Prior art date
Application number
PE2012000650A
Other languages
Spanish (es)
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of PE20121472A1 publication Critical patent/PE20121472A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMBINACION FARMACEUTICA QUE COMPRENDE: (A) TEOBROMINA Y (B) UN OPIATO TAL COMO CODEINA, MORFINA, DIAMORFINA, TEBAINA, PAPAVERINA, NOSCAPINA, ORIPAVINA, FENTANILO, ALFENTANILO, PROPOXIFENO, OXICODONA, ENTRE OTROS. DICHA COMBINACION PRESENTA UN EFECTO ANTITUSIVO POTENTE Y MAYOR QUE LA SUMA DE LOS FARMACOS INDIVIDUALESREFERS TO A PHARMACEUTICAL COMBINATION THAT INCLUDES: (A) THEOBROMINE AND (B) AN OPIATE SUCH AS CODEINE, MORPHINE, DIAMORPHINE, THEBAINE, PAPAVERIN, NOSCAPINE, ORIPAVIN, FENTHANIL, ALPHENTHANIL, PROPOXYCPHENE, OTHRENE. SUCH COMBINATION PRESENTS A POWERFUL ANTITUSSIVE EFFECT AND GREATER THAN THE SUM OF INDIVIDUAL DRUGS

PE2012000650A 2009-11-13 2010-11-12 COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY PE20121472A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0919893.8A GB0919893D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy

Publications (1)

Publication Number Publication Date
PE20121472A1 true PE20121472A1 (en) 2012-11-30

Family

ID=41509327

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012000650A PE20121472A1 (en) 2009-11-13 2010-11-12 COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY

Country Status (19)

Country Link
EP (1) EP2498776A1 (en)
JP (2) JP2013510842A (en)
CN (1) CN102740853B (en)
AU (1) AU2010317668C1 (en)
BR (1) BR112012011224A2 (en)
CA (1) CA2780704C (en)
CO (1) CO6551745A2 (en)
EC (2) ECSP12011893A (en)
GB (1) GB0919893D0 (en)
IL (1) IL219769A0 (en)
MX (1) MX2012005538A (en)
NZ (1) NZ599957A (en)
PE (1) PE20121472A1 (en)
PH (1) PH12012500955A1 (en)
RU (1) RU2587329C2 (en)
SG (1) SG10201407496SA (en)
UA (1) UA105940C2 (en)
WO (1) WO2011058374A1 (en)
ZA (1) ZA201204247B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2523588A (en) * 1987-10-08 1989-05-02 Andor Bilas Mixture of substances for stabilyzing metabolism
JPH09502201A (en) * 1993-09-07 1997-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー Composition containing amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of decongestant, expectorant, antihistamine and antitussive agent
HUP9700654A2 (en) 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
US6608073B1 (en) * 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
JP2005516917A (en) * 2001-12-12 2005-06-09 アメリカ合衆国 Methods for enhancing immune response and inflammation using extracellular adenosine inhibitors and adenosine receptor inhibitors
PT1603533E (en) * 2003-02-28 2009-07-23 Ym Biosciences Inc Opioid delivery system
CN1593451A (en) * 2003-09-12 2005-03-16 杨喜鸿 Externally applied medicine for promoting male erection
EP1844792A4 (en) * 2004-12-14 2008-05-21 Shionogi & Co Therapeutic agent for constipation
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (en) * 2006-07-25 2008-01-30 안국약품 주식회사 Cough Treatment Composition

Also Published As

Publication number Publication date
SG10201407496SA (en) 2015-02-27
CN102740853A (en) 2012-10-17
BR112012011224A2 (en) 2017-03-01
AU2010317668B2 (en) 2015-01-22
CA2780704A1 (en) 2011-05-19
NZ599957A (en) 2014-05-30
CO6551745A2 (en) 2012-10-31
ECSP12011892A (en) 2012-09-28
RU2012124063A (en) 2013-12-20
ZA201204247B (en) 2013-02-27
JP2013510842A (en) 2013-03-28
AU2010317668C1 (en) 2016-02-11
CA2780704C (en) 2018-07-17
AU2010317668A1 (en) 2012-06-07
UA105940C2 (en) 2014-07-10
EP2498776A1 (en) 2012-09-19
JP2016041748A (en) 2016-03-31
IL219769A0 (en) 2012-07-31
ECSP12011893A (en) 2012-10-30
WO2011058374A1 (en) 2011-05-19
PH12012500955A1 (en) 2013-01-07
GB0919893D0 (en) 2009-12-30
RU2587329C2 (en) 2016-06-20
CN102740853B (en) 2015-04-08
MX2012005538A (en) 2012-09-28

Similar Documents

Publication Publication Date Title
MX2012007769A (en) Random sampling for geophysical acquisitions.
HUE036912T2 (en) Conjugates of CC-1065 analogues and bifunctional linkers
BRPI0714712B8 (en) drug delivery device
AU347997S (en) Electronic device
AU345940S (en) Electronic device
AU349749S (en) Display structure
GT201200304A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE HYDROMORPHONE AND NALOXONE
AU348784S (en) Dislay stand
AU336886S (en) Electronic device
AU336415S (en) Electronic device
AU336950S (en) Fender
AU340064S (en) Scooter frame
USD761311S1 (en) Display screen or portion thereof with graphical user interface
MX2013007622A (en) A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease.
PE20121472A1 (en) COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY
PH12012501200A1 (en) Therapeutic combinations of theobromine and an antihistamine
AU335193S (en) Speaker
UA108993C2 (en) MEDICINAL COMBINATION WITH THEOBROMINE AND ITS APPLICATION IN Cough
GB201014391D0 (en) Drug composition and its use in therapy
CO6541630A2 (en) THEOBROMINE COMBINATION WITH A DESCONGESTIVO AND ITS USE FOR THE TOS TREATMENT
AU335160S (en) Speaker
AU325789S (en) Tube
AU337509S (en) Key holder
Imanaliev An Advancing Alliance
CA143686S (en) Buccal medication delivery device adapter

Legal Events

Date Code Title Description
FC Refusal